|
Bristol-Myers Squibb and Ambrx Announce Collaboration
|
22 September 2011 |
|
Bristol-Myers Squibb and Ono Enter into Strategic Agreement
|
21 September 2011 |
|
Bristol-Myers Squibb Completes Acquisition of Amira Pharmaceuticals
|
09 September 2011 |
|
Bristol-Myers Squibb Delivers Excellent Second Quarter
|
05 August 2011 |
|
Bristol-Myers Squibb to Acquire Amira Pharmaceuticals
|
22 July 2011 |
|
FDA Advisory Committee Makes Recommendation on Investigational Compound Dapagliflozin
|
21 July 2011 |
|
Bristol-Myers Squibb and Innate Pharma Announce Breakthrough Global License Agreement
|
07 July 2011 |
|
Bristol-Myers Squibb to Expand Access to Reyataz® in sub-Saharan Africa and India
|
29 June 2011 |
|
Bristol-Myers Squibb Foundation Awards $1.5 Million in Grants
|
27 June 2011 |
|
Bristol-Myers Squibb and Roche Enter into a Clinical Collaboration Agreement
|
03 June 2011 |
|
Bristol-Myers Squibb Delivers Excellent First Quarter with YERVOY™ (ipilimumab) Approval
|
29 April 2011 |
|
Phase III Study of Investigational Compound Ipilimumab Achieves Primary Endpoint
|
22 March 2011 |
|
Bristol-Myers Squibb Delivers Solid Fourth Quarter Results
|
27 January 2011 |
|
Pediatric Exclusivity For PLAVIX®
|
25 January 2011 |
|
People to Actively Manage Their Type 2 Diabetes
|
11 January 2011 |
|
KOMBIGLYZE™ XR Now Available in U.S. Pharmacies
|
09 January 2011 |
|
Bristol-Myers Squibb and Oncolys BioPharma Enter Global Licensing Agreement
|
21 December 2010 |
|
Encouraging Phase 2 Interim Data for Elotuzumab in Relapsed Multiple Myeloma
|
07 December 2010 |
|
Bristol-Myers Squibb and Alvin Ailey American Dance Theater Announce First-of-Its-Kind Collaboration
|
01 December 2010 |
|
APPRAISE-2 Study with Investigational Compound Apixaban Discontinued
|
21 November 2010 |